Batu Biologics
Advertising Networks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9255 Towne Centre Dr Ste 450, San Diego,...Phone Number
(213) 359-3179Website
www.batubiologics.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Batu Biologics
Batubiologics specializes in providing resources and guidance for aspiring content creators in the digital landscape. Their services include tips on content creation, marketing strategies, and the effective use of social media platforms. The company targets individuals looking to establish a career in content creation, offering insights into best practices and industry trends. Through their blog, they aim to empower users with knowledge on various aspects of content marketing and audience engagement.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Batu Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Batu Biologics recently announced quarterly report
Check if Batu Biologics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Batu Biologics launches new products
Click to see if Batu Biologics had a recent Job posting/layoffs
Check out if Batu Biologics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Batu Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Batu Biologics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Batu Biologics
Recommended Actions
Find VP level buyers at Batu Biologics
Find more new buyers
Compare Similar Companies to Batu Biologics
Compare insights from companies similar to Batu Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Batu Biologics
$5.3M
1-10
Private
<$5M
2013
N/A
Company Profile Activity
Activity Insights
Batu Biologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Batu Biologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Batu Biologics.
Batu Biologics financials insights
Gather financial insights about Batu Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Angel/Seed
$1M
2016
Private Equity
$508K
2017
Angel/Seed
$1.3M
Batu Biologics Tech Stack
A closer look at the technologies used by Batu Biologics
Batu Biologics News & Media
Batu Biologics Recruits Dr. Vijay Mahant as the Vice President of Precision Oncology to Oversee the Personalization of ValloVax Immunogenicity
SAN DIEGO--(BUSINESS WIRE)--Today, Batu Biologics announced the recruitment of Dr. Vijay Mahant to the management team in the position of Vice President of Precision Oncology. Under this role, Dr. Mahant will assist with the optimization of the clinical development of ValloVax, with a focus on identifying methods to stratify patients based on biomarkers that may be able to predict response to therapy. “Recently, the Company has identified correlations in the expression of specific HLA allelesBatu Biologics Announces the Release of the Starve The Tumor Immunotherapy Blog
SAN DIEGO--(BUSINESS WIRE)--Today, Batu Biologics announced the release of the Starve The Tumor Video Blog, a series of informational videos and articles designed to provide background information on our lead therapeutic ValloVax. Batu Biologics’ lead clinical candidate, ValloVax, is a first-in-class placenta derived endothelial cell based vaccine designed to stimulate an immune response against several tumor angiogenesis associated antigens for the treatment of solid tumor carcinomas. CurrentlBatu Biologics Identifies Gene Types Associated with Response to ValloVax
SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, a clinical stage immuno-oncology Company, announced today the filing of a patent application covering methods of selecting patients likely to respond to ValloVax. ValloVax is a placental endothelial cell based immunotherapy that is designed to stimulate an immune response against several antigens associated with tumor blood vessel formation, or angiogenesis. “It is well established in the area of organ transplantation that the rate and degree of tissuBatu Biologics Files Patent on Patient Selection for Right to Try Law
SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today filing of a patent covering methods of matching cancer patients with experimental drugs under the new Right to Try Law. The recently passed law allows for companies that have passed Phase I of clinical trial to start offering terminal patients access to drugs that are still in development. “While there has been a great amount of interest generated by the recently passed `Right to Try' law, major ethical questions
Read more news
Top Advertising Networks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Batu Biologics
Sign Up For FreeTo access detailed company insights
Batubiologics specializes in providing resources and guidance for aspiring content creators in the digital landscape. Their services include tips on content creation, marketing strategies, and the effective use of social media platforms. The company targets individuals looking to establish a career in content creation, offering insights into best p... Read More
